Letrozole Tablet, Film Coated
Product Images NDC 69117-0004

8 FDA label images from Yiling Pharmaceutical, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 69117-0004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Yiling Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (11005a48 13fd 4c6d A024 1e39e3528e45 01)

Figure-1 (11005a48 13fd 4c6d A024 1e39e3528e45 01)
Chemical structure of Letrozole, displaying its molecular configuration as seen in the image. The structure includes two nitrile groups and a triazole ring system characteristic of Letrozole.*
FDA Label Image

Figure-2 (Figure 1 Disease Free Survival Median Follow Up 73 Months Itt Approach)

Figure-2 (Figure 1 Disease Free Survival Median Follow Up 73 Months Itt Approach)
A Kaplan-Meier survival curve comparing Letrozole and Tamoxifen treatments over 72 months. The y-axis represents the proportion of patients without event, ranging from 0 to 1. The x-axis shows time in months from 0 to 72. The curve for Letrozole is a solid line, and Tamoxifen is a dashed line.*
FDA Label Image

Figure-3 (Figure 2 Kaplan Meier Estimates Of Time To Progression Tamoxifen Study)

Figure-3 (Figure 2 Kaplan Meier Estimates Of Time To Progression Tamoxifen Study)
A Kaplan-Meier survival curve comparing progression-free survival over time in months between Letrozole 2.5 mg and Tamoxifen 20 mg. The y-axis indicates the proportion of progression-free subjects, ranging from 0 to 1.0, with two lines representing each treatment group for up to 60 months.*
FDA Label Image

Figure-4 (Figure 3 Survival By Randomized Treatment Arm)

Figure-4 (Figure 3 Survival By Randomized Treatment Arm)
A survival curve graph comparing the proportion of subjects alive over a period of up to 60 months, with separate lines for Letrozole first and Tamoxifen first treatment groups. The x-axis represents months, and the y-axis represents the fraction alive from 0 to 1.*
FDA Label Image

Figure-5 (Figure 4 Kaplan Meier Estimates Of Time To Progression Megestrol Acetate Study)

Figure-5 (Figure 4 Kaplan Meier Estimates Of Time To Progression Megestrol Acetate Study)
A Kaplan-Meier survival curve chart comparing time to progression in days for three treatment groups: Letrozole 0.5 mg, Letrozole 2.5 mg, and a group labeled MA. The graph shows survival probabilities on the y-axis against time on the x-axis, illustrating the progression rates over approximately 900 days.*
FDA Label Image

Figure-6 (Figure 5 Kaplan Meier Estimates Of Time To Progression Amino)

Figure-6 (Figure 5 Kaplan Meier Estimates Of Time To Progression Amino)
A survival curve chart comparing time to progression in days for two treatment groups: Letrozole 0.5 mg and Letrozole 2.5 mg. The x-axis represents time to progression, ranging up to approximately 900 days, and the y-axis represents the proportion of patients progressing, from 0 to 1. The chart illustrates differences in progression over time between the two dosage groups.*
FDA Label Image

Figure 6

Figure 6
Letrozole 2.5 mg film-coated round orange tablets, oral dosage form. One side is imprinted with '121' and the other side with 'YL'. Manufactured by Yiling Pharmaceutical, Inc.*
FDA Label Image

Figure-7 (Label)

Figure-7 (Label)
Label for Letrozole Tablets, USP 2.5 mg by Yiling Pharmaceutical, Inc. This film-coated oral tablet package contains 30 tablets. The label includes dosage and storage information, manufacturer details (Beijing Yiling Bio-engineering Technology Co., Ltd.), and color additive information (FD&C Yellow No.5). It shows the NDC 69117-0004-1 and cautionary notes to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.